Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology

The U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations, Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960’s, have we...

Full description

Bibliographic Details
Main Authors: Wendy E. Roberts, Neil S. Sadick, Wilma F. Bergfeld, Amy S. Paller, Valerie D. Callender, Lynn A. Drake
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:International Journal of Women's Dermatology
Online Access:http://www.sciencedirect.com/science/article/pii/S2352647517300886
id doaj-9b4b69862864428f8055315cca401135
record_format Article
spelling doaj-9b4b69862864428f8055315cca4011352020-11-25T02:32:56ZengElsevierInternational Journal of Women's Dermatology2352-64752017-12-0134239243Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in DermatologyWendy E. Roberts0Neil S. Sadick1Wilma F. Bergfeld2Amy S. Paller3Valerie D. Callender4Lynn A. Drake5Generational and Cosmetic Dermatology, Rancho Mirage, CA, USASadick Dermatology, New York, NY, USACleveland Clinic Foundation, Cleveland, OH, USANorthwestern University, Chicago, IllinoisCallender Dermatology & Cosmetic Center, Glenn Dale, MD, USAHarvard Medical School, Boston, MA, USAThe U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations, Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960’s, have we seen such widespread changes in the medical healthcare environment (Centers for Medicare and Medicaid Services). Physicians, industry, patients and consumers are affected by the changes. These four groups have historically worked as separate entities, but are now key stakeholders in the future of dermatology. As stakeholders collaborating in building a future together, the dermatologists/physicians will help to ensure and preserve the quality of patient care and best patient outcomes. In 2 Executive Forum meetings February 21-23, 2014 and June 3-4, 2016 the leaders from the Women’s Dermatologic Society and Industry, explored several important areas, six of which will be reviewed in this article 1) A five-year outlook of Dermatology and Medicine; 2) The New Practice Environment; 3) Access of Industry to Dermatologists and Trainees; 4) Doing Things Differently; and 5) Female Leadership 6) Unmet Needs. The collaborative group explored solutions for our specialty and the patients we serve.http://www.sciencedirect.com/science/article/pii/S2352647517300886
collection DOAJ
language English
format Article
sources DOAJ
author Wendy E. Roberts
Neil S. Sadick
Wilma F. Bergfeld
Amy S. Paller
Valerie D. Callender
Lynn A. Drake
spellingShingle Wendy E. Roberts
Neil S. Sadick
Wilma F. Bergfeld
Amy S. Paller
Valerie D. Callender
Lynn A. Drake
Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
International Journal of Women's Dermatology
author_facet Wendy E. Roberts
Neil S. Sadick
Wilma F. Bergfeld
Amy S. Paller
Valerie D. Callender
Lynn A. Drake
author_sort Wendy E. Roberts
title Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
title_short Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
title_full Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
title_fullStr Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
title_full_unstemmed Physician-Industry Collaboration: Organizational Considerations for the Future of Innovation and Growth in Dermatology
title_sort physician-industry collaboration: organizational considerations for the future of innovation and growth in dermatology
publisher Elsevier
series International Journal of Women's Dermatology
issn 2352-6475
publishDate 2017-12-01
description The U.S. medical environment continues to evolve with issues from Privacy to EMR, Insurance regulations, Physician Access and Healthcare Reform, and MACRA (Medicare Access and CHIP Reauthorization Act) on the discussion table. Not since the advent of Medicare and Medicaid in the mid 1960’s, have we seen such widespread changes in the medical healthcare environment (Centers for Medicare and Medicaid Services). Physicians, industry, patients and consumers are affected by the changes. These four groups have historically worked as separate entities, but are now key stakeholders in the future of dermatology. As stakeholders collaborating in building a future together, the dermatologists/physicians will help to ensure and preserve the quality of patient care and best patient outcomes. In 2 Executive Forum meetings February 21-23, 2014 and June 3-4, 2016 the leaders from the Women’s Dermatologic Society and Industry, explored several important areas, six of which will be reviewed in this article 1) A five-year outlook of Dermatology and Medicine; 2) The New Practice Environment; 3) Access of Industry to Dermatologists and Trainees; 4) Doing Things Differently; and 5) Female Leadership 6) Unmet Needs. The collaborative group explored solutions for our specialty and the patients we serve.
url http://www.sciencedirect.com/science/article/pii/S2352647517300886
work_keys_str_mv AT wendyeroberts physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
AT neilssadick physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
AT wilmafbergfeld physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
AT amyspaller physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
AT valeriedcallender physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
AT lynnadrake physicianindustrycollaborationorganizationalconsiderationsforthefutureofinnovationandgrowthindermatology
_version_ 1724816692804059136